Active Ingredient(s): Levoleucovorin
FDA Approved: * October 19, 2018
Pharm Company: * SPECTRUM PHARMS
Category: Antidotes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Khapzory Overview

Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine.[2][3] It is also used in combination with 5-fluorouracil to treat colorectal cancer, may be used to treat folate deficiency that results in anemia, and methanol poisoning.[3][4] It is taken by mouth, injection into a muscle, or injection into a vein.[3] Side effects may include trouble slee...

Read more Khapzory Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Khapzory Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 50mg
  • Powder: 175mg/17.5ml (10mg/ml), 175mg/vial, 250mg/25ml (10mg/ml), 300mg/vial, 50mg/vial
  • Solution: 175mg/17.5ml (10mg/ml), 250mg/25ml (10mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Khapzory: (2 results)

Sorted by National Drug Code
  • 68152-112 Khapzory 175 mg/3.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Spectrum Pharmaceuticals, Inc.
  • 68152-114 Khapzory 300 mg/6ml Intravenous Injection, Powder, Lyophilized, for Solution by Spectrum Pharmaceuticals, Inc.

Other drugs which contain Levoleucovorin or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA